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Abstract
Dissemination of carbapenem resistance among pathogenic Gram-negative bacteria is a looming medical emergency.
Efficient spread of resistance within and between bacterial species is facilitated by mobile genetic elements. We
hypothesized that wastewater contributes to the dissemination of carbapenemase-producing Enterobacteriaceae (CPE),
and studied this through a cross-sectional observational study of wastewater in the East of England. We isolated
clinically relevant species of CPE in untreated and treated wastewater, confirming that waste treatment does not
prevent release of CPE into the environment. We observed that CPE-positive plants were restricted to those in direct
receipt of hospital waste, suggesting that hospital effluent may play a role in disseminating carbapenem resistance. We
postulated that plasmids carrying carbapenemase genes were exchanged between bacterial hosts in sewage, and used
short-read (Illumina) and long-read (MinION) technologies to characterize plasmids encoding resistance to antimicrobials
and heavy metals. We demonstrated that different CPE species (Enterobacter kobei and Raoultella ornithinolytica) isolated
from wastewater from the same treatment plant shared two plasmids of 63 and 280 kb. The former plasmid conferred
resistance to carbapenems (blaOXA-48), and the latter to numerous drug classes and heavy metals. We also report the
complete genome sequence for Enterobacter kobei. Small, portable sequencing instruments such as the MinION have the
potential to improve the quality of information gathered on antimicrobial resistance in the environment.
DATA SUMMARY
1. Illumina sequence data have been deposited in the European
Nucleotide Archive (ENA); individual sample accession num-
bers are as listed in Table 1. MinION sequence data have
been deposited in ENA; accession numbers: ERS634378,
ERS634376 and ERS1033541 (www.ebi.ac.uk/ena/data/view/
ERS634378, www.ebi.ac.uk/ena/data/view/ERS634376, www.
ebi.ac.uk/ena/data/view/ERS1033541).
2. Supporting data, including assemblies and the fast52fastq.
py script, are available from a GitHub repository (https://
github.com/kim-judge/wastewater).
3. The manually finished genome of Enterobacter kobei
has been deposited in ENA under accession numbers:
FKLS01000001–FKLS01000010 (www.ebi.ac.uk/ena/data/view/
FKLS01000001 –www.ebi.ac.uk/ena/data/view/FKLS01000010).
INTRODUCTION
The global rise of carbapenemase-producing Enterobacter-
iaceae (CPE) over the last decade represents a major threat
to public health [1–3]. CPE are often resistant to several
additional classes of antibiotics, which may limit thera-
peutic options to drugs with a higher toxicity profile. Unsur-
prisingly, invasive infections caused by CPE are associated
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with poor clinical outcomes and carry an excess attributable
mortality compared with those caused by carbapenem-
susceptible isolates [4–6]. CPE are predominantly isolated
in healthcare settings, but their spread to healthy humans,
livestock and the environment has been reported [4, 7]. The
development of interventions that prevent further CPE dis-
semination requires delineation of their reservoirs and
routes of spread, combined with accurate characterization
of the mobile elements that transfer carbapenemase genes
within and between bacterial species.
High-throughput whole-genome sequencing (WGS) has pro-
vided major insights into pathogen transmission and outbreak
investigation based on core-genome phylogenetic analyses [8],
but has not reached its potential to provide detailed characteri-
zation of plasmids and their transmission within specific envi-
ronments. This is due to a methodological limitation of
short-read data generated by Illumina technology, from which
plasmids cannot be accurately assembled because of the pres-
ence of numerous repetitive regions. Technologies including
the Pacific BioSciences RSII system (PacBio) and the Oxford
Nanopore Technologies MinION system generate long-read
data that can overcome this barrier. It has been demonstrated
previously that PacBio long-read sequencing can be success-
fully used to elucidate transfer of carbapenem-resistance-
carrying plasmids within hospital environments [9, 10], and
after years of on-going development the pocket-sized MinION
is approaching a level of accuracy and usability at which it
could be used to explore the central question of plasmid trans-
mission. It has been used previously to detect the presence of
antimicrobial-resistance genes and to track the transmission
of viral outbreaks [11–14].
Our aim here was to apply the MinION and Illumina plat-
forms to seek evidence for sharing of carbapenemase-encod-
ing plasmids between bacterial species in human sewage. This
reservoir contains a diversity of pathogenic and non-patho-
genic bacteria that can exchange DNA (including genes
encoding antimicrobial resistance) by horizontal gene transfer.
CPE have been isolated from human sewage at wastewater
treatment plants in Austria, Germany and Brazil, and from
rivers and lakes in Switzerland, Portugal, Brazil and Vietnam
[15–22], and carbapenemase-encoding plasmids have been
found in wastewater in Germany [21], but definitive evidence
of plasmid sharing and putative transmission is lacking.
METHODS
Wastewater processing and bacterial identification
Samples of treated and untreated wastewater were obtained
from each of 20 treatment plants. At each sampling point, two
consecutive grab samples of 0.5 l each were collected and
mixed in 1 l sterile bottles containing 18mg sodium thiosul-
phate (Sigma-Aldrich). A single 1 l wastewater sample was
obtained from the main septic tank at the Cambridge Univer-
sity Hospitals NHS Foundation Trust (CUH) facility. All sam-
ples were transported to the laboratory on ice packs in the
dark and processed within 12 h. One millilitre of triplicate
serial tenfold dilutions, 10ml untreated wastewater samples
and 100ml treated wastewater samples were concentrated
using the filtration technique onto 0.45 µm pore size filter
membranes (S-Pak; Merck Millipore). Membranes were then
placed onto the surface of ESBL Brilliance agar (Oxoid) and
incubated for 24 h at 37

C in air. Duplicate membranes of the
lowest dilution tested were also placed into tryptic soy broth
with 2mg imipenem l 1 and incubated for 24 h at 37

C in air,
followed by subculture of 100 µl on chromID CARBA SMART
plates (bioMerieux), and ESBL Brilliance and cystine lactose
electrolyte deficient (CLED) agar with a 10 µg imipenem disc.
At least one colony for each bacterial colony morphology
type suspected to be Enterobacteriaceae based on colour
were picked and speciated using matrix-assisted laser desorp-
tion/ionization-time of flight mass spectrometry (MALDI-
TOF MS; Biotyper version 3.1; Bruker Daltonics). Antimi-
crobial-susceptibility testing was determined using the N206
card on the Vitek 2 instrument (bioMerieux) calibrated
against European Committee on Antimicrobial Susceptibility
Testing (EUCAST) breakpoints. Minimum inhibitory con-
centrations (MICs) of meropenem, ertapenem, imipenem
and colistin were determined using Etest (bioMerieux) for
any isolate with reduced susceptibility to carbapenems on
IMPACT STATEMENT
The spread of carbapenem resistance among pathogenic
Gram-negative bacilli is a major public-health threat. Stud-
ies to date have emphasized this problem in the clinical
setting, largely ignoring the importance of environmental
contamination and the significance of a One Health
approach. The use of Illumina whole-genome sequencing
to identify the genetic basis for resistance led to the discov-
ery that several species from the same treatment plant
carried the same carbapenem-resistance gene. Using the
Oxford Nanopore MinION, we demonstrated putative
sharing of several plasmids between different Enterobac-
teriaceae species (Enterobacter kobei and Raoultella orni-
thinolytica) in wastewater, with one plasmid carrying a
carbapenemase gene conferring resistance to the carba-
penem drugs, and the other containing resistance genes to
numerous other drugs and heavy metals. To our knowl-
edge, this is the first report of carbapenemase-producing
Enterobacteriaceae being recovered from wastewater at
UK sewage treatment plants. Importantly, we show that
treatment plants do not prevent the release of these bac-
teria into the environment and this may provide a point of
intervention. We also demonstrate the utility of a next-
generation sequencing instrument, the MinION, to confirm
the sharing of plasmids between bacterial isolates in
wastewater, and have generated a complete genome
sequence for Enterobacter kobei. The ease of use of this
instrument would facilitate its implementation in future
intervention studies that target environmental contamina-
tion with carbapenem-resistance genes.
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Vitek 2. Enterobacteriaceae with confirmed resistance to any
carbapenem underwent further phenotypic testing using the
KPC/MBL and OXA-48 Confirm kit (Rosco Diagnostica) to
detect production of KPC, MBL and OXA-48 carbapene-
mases. All CPE (n=16) identified were de-duplicated for spe-
cies and type of carbapenemase according to sample
location, and further analysed using WGS (n=9).
Illumina sequencing and bioinformatic analyses
DNA extraction and library preparation were performed as
previously described [23]. DNA libraries were sequenced
using the Illumina HiSeq and MiSeq platforms (Illumina) to
generate 100 and 150 bp paired-end reads, respectively. De
novo multi-contig draft assemblies were generated using
Velvet Optimiser and Velvet [24]. Contigs smaller than 300
bases were removed, the scaffolding software SSPACE was
employed, and assemblies further improved using GapFiller.
For isolates belonging to the Enterobacter cloacae complex,
species identification was based on analysis of hsp60 and
rpoB, as described elsewhere [25]. To detect acquired genes
encoding antimicrobial resistance, a manually curated ver-
sion of the ResFinder database (compiled in 2012) [26] was
used. Assembled sequences were compared to this as
described previously [27], and genes with 100% match to
length and >90% identity match were classified as present
and variants identified. To establish genetic relatedness
between Raoultella ornithinolytica isolates, Illumina
sequence reads were mapped to the reference genome B6
(GenBank accession no. CP004142) using SMALT v0.7.4 to
identify single-nucleotide polymorphisms (SNPs). SNPs
were filtered to remove those at sites with a SNP quality
score below 30, and SNPs at sites with heterogeneous map-
pings were filtered out if the SNP was present in less than
75% of reads at that site. Sequence data have been deposited
in the European Nucleotide Archive (www.ebi.ac.uk/ena)
under the individual accession numbers given in Table 1.
MinION sequencing and bioinformatic analyses
Isolates were streaked from frozen stock onto blood agar
plates and incubated in air at 37

C overnight. A sweep of col-
onies was taken and DNA extraction carried out using the
QiaAMP DNA mini kit (Qiagen) and quantified using the
Qubit fluorometer and BR kit (Life Technologies). Genomic
DNA was diluted in 10mM Tris-HCl to a concentration of
Positive wastewater
Negative wastewater
Hospital
20 km100
Fig. 1. Map of wastewater treatment plants in the East of England tested for CPE. Black dots, negative for CPE; red dots, positive for
CPE. Plants positive for CPE are numbered 1–4. Sewer refers to sampling at the CUH facility. Hospitals situated upstream of the study
wastewater treatment plants (approximate median distance of 5.3 km; range 3.3–9.6 km) are denoted by H.
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1500ng in 46 µl and sheared using G-TUBES (Covaris). Min-
ION sample preparation and two-dimensional sequencing
was carried out as previously described using the SQK-MAP-
006 kit and R7.3 flow cells [28]. Basecalling was carried out
using the Metrichor two-dimensional basecalling option using
version 1.15.7 for VRES0269 and VRES0273, and version
1.20.5 for VRES0259.
Basecalled MinION reads were converted from FAST5 to
FASTQ and FASTA formats using fast52fastq.py (https://
github.com/kim-judge/wastewater). Read mapping was car-
ried out to assess the quality of data and coverage using the
BWA-MEM algorithm of BWA v0.7.12 with the flag –x ont2d
[29]. Output SAM files from BWA-MEM were converted to
sorted BAM files using SAMtools v0.1.19-44428 cd [30].
Assembly using MinION data only was undertaken using
Canu [31, 32], followed by Circlator [33] 1.2.0. Canu ver-
sion 1.0 was run using the commands maxThreads=8, max-
Memory=16, useGrid=0, nanopore-raw. Hybrid assemblies
were generated using SPAdes 3.6 [34] using the –nanopore
and –careful flags, then filtered to exclude contigs of less
than 1 kb. All plasmid sequences and the chromosomes
were confirmed to be circular by the Circlator software
1.2.0. Assembly statistics were analysed using assembly-stats
(https://github.com/sanger-pathogens/assembly-stats). All
assemblies were annotated using Prokka 1.5 [35, 36].
Assemblies were compared using the Artemis comparison
tool [37] and further analysed using Artemis [38]. Plasmid
sequences and other regions of interest were investigated
using the BLASTN suite at National Center for Biotechnology
Information (http://www.ncbi.nlm.nih.gov).
Manually finished genome
Assemblies were generated using Canu and SPAdes as
described above. A gap5 database was made using corrected
MinION pass reads from the Canu pipeline and the Illumina
reads. Manual finishing was undertaken using gap5 [39] ver-
sion 1.2.14 making one chromosome and nine plasmids.
Icorn2 [40] was run on this for five iterations. The start posi-
tions of the chromosome and plasmids were fixed using Cir-
clator [33] 1.2.0 using the command circlator fixstart. This
assembly was annotated using Prokka 1.5 [35, 36].
Regional surveillance of CPE
Information was retrieved on all CPE isolates referred from
diagnostic microbiology laboratories in the East of England to
Public Health England’s Antimicrobial Resistance and Health-
care Associated Infections (AMRHAI) Reference Unit
between 2006 and 2015 (Table S1, available in the online Sup-
plementary Material). KPC-, OXA-48-like-, NDM-, VIM- and
Table 2. Antimicrobial susceptibility of CPE isolated from wastewater
Isolate ID Species
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VRES0316 Escherichia coli >32 16 8 0.5 ≥64 ≥64 ≤2 ≥32 ≤1 ≥64 ≥4 ≥8 ≥16 ≤1 ≥128 ≤0.5 ≥16
VRES0375 Klebsiella pneumoniae >32 16 8 0.5 ≥64 ≥64 16 ≥32 ≤1 ≥64 ≥4 ≥8 ≥16 ≥16 ≥128 ≥8 ≥16
VRES0377
Enterobacter cloacae
complex >32 4 4 0.5 ≥64 ≥64 ≤2 ≥32 ≤1 ≥64 ≤0.25 ≥8 ≥16 ≥16 ≥128 NI 8
VRES0379 Klebsiella oxytoca >32 16 16 0.25 ≥64 ≥64 ≤2 ≥32 ≥64 ≥64 2 ≥8 ≥16 ≥16 ≥128 ≤0.5 ≥16
VRES0380 Klebsiella pneumoniae >32 >32 16 0.25 ≥64 ≥64 ≥64 ≥32 ≥64 ≥64 ≥4 ≥8 ≥16 ≥16 ≥128 4 ≥16
VRES0269
Raoultella
ornithinolytica 2 1 2 0.5 ≥64 4 ≤2 ≥32 ≥64 ≤1 ≤0.25 ≥8 2 ≥16 ≥128 1 ≤0.5
VRES0273 Enterobacter kobei >32 >32 >32 0.5 ≥64 32 ≤2 ≥32 ≥64 8 2 ≥8 ≥16 ≥16 ≥128 NI ≤0.5
VRES0259
Raoultella
ornithinolytica 2 2 2 0.5 ≥64 ≤1 ≤2 ≥32 ≥64 ≤1 ≤0.25 ≥8 1 ≥16 ≥128 ≤0.5 ≤0.5
VRES0183 Klebsiella pneumoniae >32 >32 >32 0.5 ≥64 ≥64 8 ≥32 ≥64 16 ≥4 ≥8 ≥16 ≥16 ≥128 2 4
COL, Colistin; ETP, ertapenem; IPM, imipenem; MEM, meropenem; NI, non-identifiable by VITEK.
Red shading, resistant; blue shading, intermediate resistance; white/no shading, susceptible.
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IMP-encoding genes were detected by in-house PCR and/or
commercial microarray, which was performed by the AMR-
HAI Reference Unit using published methods [41–46].
RESULTS
Isolation of CPE from wastewater
We undertook a cross-sectional study of 20 municipal
wastewater treatment plants in the East of England between
June 2014 and January 2015. Plant location was selected
with reference to hospital waste, with ten plants situated
immediately downstream of acute NHS Hospital Trust
facilities (approximate median distance between wastewater
treatment plant and respective hospital 5.3 km, range 3.3–
9.6 km) and ten plants not connected to acute hospital
effluent (Fig. 1). Paired samples of untreated and treated
wastewater were obtained from each plant. The main septic
tank at the CUH facility was also sampled in September
2014. CPE were isolated using filtration and culture proce-
dures (see Methods).
CPE were isolated from four plants and the CUH sewer (see
Fig. 1 for locations). All four positive plants directly received
hospital effluent. A total of nine bacterial isolates belonging
to six species were cultured, all of which may cause human
infection (Table 1). E. coli (n=1) and R. ornithinolytica
(n=1) were isolated from treated water that was destined for
release into the environment, and Klebsiella pneumoniae
(n=3), Klebsiella oxytoca (n=1), Enterobacter cloacae com-
plex (n=2) and R. ornithinolytica (n=1) were isolated from
untreated water. In one case, the same species (R. ornithino-
lytica) was isolated from pre- and post-treated water sam-
pled from the same plant.
Phenotypic evaluation of antimicrobial resistance
To characterize the carbapenemases in the nine isolates, we
first used a phenotypic method that detects the three
main biochemical groups of carbapenemases in Enterobac-
teriaceae. This identified a class A serine carbapenemase in
K. pneumoniae, class B metallo-b-lactamases (MbLs) in E.
coli, K. pneumoniae and Enterobacter cloacae complex, and
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OXA-48
KPC
IMP
VIM
Fig. 2. CPE isolates referred from diagnostic microbiology laboratories in the East of England to the AMRHAI Reference Unit between
2008 and 2015. One representative of the same CPE per month per hospital is shown. One sample received by PHE in 2006
was excluded as date of isolation was unknown. See Table S1 for a complete list of all isolates.
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class D OXA-48-like carbapenemases in Enterobacter cloa-
cae complex, K. pneumoniae, K. oxytoca and the two R.
ornithinolytica (Table 1). Susceptibility testing was con-
ducted against a panel of antimicrobials, and demonstrated
that all nine isolates were resistant to at least five antibiotic
drug groups (Table 2).
Comparison between wastewater findings and
geographically related clinical isolates
To compare our findings with carbapenem-resistance
mechanisms present in isolates cultured in the clinical set-
ting in the same region, we collated data gathered by Public
Health England on all CPE isolates referred by 16 diagnostic
microbiology laboratories in the East of England to their
AMRHAI Reference Unit for further characterization
between 2006 and 2015. This identified 115 CPE isolates
belonging to nine different Enterobacteriaceae species and
harbouring carbapenemases belonging to classes A, B and D
(Table S1). K. pneumoniae, Escherichia coli and members of
the Enterobacter cloacae complex accounted for 43, 38 and
8% of isolates, respectively. The same bacterial species and
carbapenemase gene (NDM) was observed in 2 wastewater
treatment plants (numbered 1 and 2, Fig. 2) located down-
stream of hospitals where such CPEs were also identified.
Genetic characterization of antimicrobial resistance
The entire repertoire of resistance genes/mechanisms was
characterized in the nine study isolates by performing WGS
using Illumina short-read technology, followed by comparison
of each genome to a comprehensive database of genes/gene
variants that encode drug resistance (See Methods for details).
From this, we identified carbapenemases in class A (GES-5),
class B [NDM-5, NDM-1-like (differed from NDM-1 by 1 aa
change) and IMP-1] and class D (OXA-48 and OXA-181)
(Table 1), which are known to be carried by mobile genetic
elements. Three isolates with high imipenem resistance also
had truncated versions of porin proteins due to insertion
sequences, stop mutations and frameshift mutations identified
in ompC and ompF genes (Table 1). Disruption of these
genes have been associated previously with high levels of car-
bapenem resistance [47]. Genes conferring resistance to multi-
ple classes of antimicrobials were identified in all nine isolates,
with gentamicin, quinolone and sulphonamide resistance
being the most prevalent (Table 1).
Three CPE isolates were recovered from the same treatment
plant: Enterobacter cloacae complex VRES0273 and R. orni-
thinolytica VRES0269 from pre-treated water, and R. orni-
thinolytica VRES0259 from post-treated water. VRES0273
was identified as Enterobacter kobei based on analysis of
hsp60 and rpoB, as described elsewhere [25, 48]. To assess
the core genetic relatedness of the two R. ornithinolytica iso-
lates, we aligned Illumina reads from both against the refer-
ence genome R. ornithinolytica B6 [49]. This identified that
both genomes were over 18 000 SNPs different from the ref-
erence over a core genome length of 5 398 151 bp (equating
to 99.7% identity), but only 13 SNPs different between each
other. This indicates a very high degree of relatedness. In
addition, both R. ornithinolytica isolates had identical anti-
biotic-resistance patterns for 14/15 antimicrobials tested
(Table 2). The three CPE isolates from this plant all con-
tained the blaOXA-48 gene conferring carbapenem resistance
and the same non-b-lactam-resistance genes (Table 1).
Sharing of resistance plasmids between
Enterobacteriaceae in wastewater
We hypothesized that resistance was mediated by one or more
plasmids that were shared between these three isolates. We
first examined the Illumina data alone to determine whether a
plasmid carrying the blaOXA-48 gene was the same in the three
isolates, but predictably we failed to assemble complete plas-
mid sequence from this short-read data. From this, we were
unable to conclude whether plasmids were shared, nor their
specific content. The blaOXA-48 gene was located on contigs of
E. kobei
VRES0273
R. ornithinolytica
VRES0269
R. ornithinolytica
VRES0259
1 Mb
MDR plasmid blaOXA-48 plasmidChromosome
Chromosome
Chromosome
Fig. 3. Comparison of whole-genome assemblies of Enterobacter kobei and R. ornithinolytica isolates using the Artemis comparison
tool. The grey and dark blue vertical blocks represent BLAST hits between the isolates in the same orientation or in the inverted orienta-
tion, respectively. Only hits longer than 1 kb are shown. Contigs are highlighted in alternating orange and brown colours. The MDR
plasmid is highlighted in light blue, and the blaOXA-48 plasmid is highlighted in purple.
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2.5 kb (VRES273), 3.6 kb (VRES269) and 3.4 kb (VRES259) in
the Illumina assemblies. To overcome this, DNA from the
three isolates was sequenced using the MinION system to gen-
erate long-read data and assembled as described in Methods.
From this we assembled a manually finished genome sequence
for Enterobacter kobei (VRES0273), which represents the first
complete whole-genome sequence for this species, and high-
quality draft assemblies for the two R. ornithinolytica isolates.
Tables 3 and S2 summarize the Illumina and MinION
sequencing data. Using these assemblies, we were able to con-
firm the close genetic relationship between the two
R. ornithinolytica isolates by mapping each against the other.
These were 12 SNPs different over 5 344 247 aligned bases in a
chromosome of 5 462 249 bp (VRES0269) and 5 334 936
aligned bases in a chromosome of 5 392 238 bp (VRES0259),
corresponding to 99.9% identity in both cases, and covering
97.8 and 98.9% of the genome, respectively. One large geno-
mic difference was present between the two isolates due to
the absence of one of the four phages in VRES0259 (Fig. 3).
One contig from each isolate (74 kb in Enterobacter kobei,
69 kb in R. ornithinolytica VRES259 and 63 kb in R. ornithino-
lytica VRES269) contained the blaOXA-48 gene (Fig. 4a). Based
on BLAST searches and assembly comparisons using the Arte-
mis comparison tool, these contigs showed synteny and
orthology to other widespread IncL/M-type blaOXA-48 plas-
mids in Enterobacter cloacae, R. ornithinolytica and K. pneu-
moniae (GenBank examples: JN626286.1, KP061858.1,
NC_023027.1, CVRH01000036 to CVRH01000038 and
LN864819.1) [41, 50–54]. The plasmids from the three isolates
were identical to each other over a shared region of 63 kb,
with zero SNPs difference. Variation in overall size was due to
hypothetical proteins integrated via insertion sequence (IS)
elements. There were several transposases, which were located
around the blaOXA-48 gene and forming part of the Tn1999
transposon (Fig. 4a). Similar variation in plasmids encoding
other carbapenemases has been identified in isolates from dif-
ferent species at a single hospital [9, 10].
We also identified a 297 kb contig in Enterobacter kobei, a
318 kb contig in R. ornithinolyticaVRES259 and a 281 kb con-
tig in R. ornithinolytica VRES269 from long-read data (Fig. 3).
All three contigs were identified as an IncHI2 type plasmid
using in silico PCR [55]. These carried heavy-metal-resistance
genes for mercury, tellurium and arsenic, and conjugational
transfer genes that facilitate plasmid transfer between different
species of Enterobacteriaceae (Fig. 3b). A multidrug-resistance
region similar to those found in Enterobacter cloacae [56]
(GenBank examples: CP012170.1, EU855788.1, CP008899.1)
was also identified in this plasmid, which contained resistance
genes for aminoglycosides [(aac(6¢)-IIc, aac(6¢)-Ib), ethidium
bromide (emrE), rifampicin (arr2), quinolones (qnrA1), sul-
phonamides (sul1, sul2) and third-generation cephalosporins
(blaSHV-12)]. This multidrug-resistance region was flanked by
transposases, indicating the potential for excision and hori-
zontal gene transfer (Fig. 4b). The shared plasmid had a com-
mon 280 kb region, which contained three SNPs between the
Enterobacter kobei plasmid and the other two plasmids, and
zero SNPs between the R. ornithinolytica plasmids.
Table 3. Assembly statistics for the nine CPE isolates based on Illumina and MinION data
Isolate ID Species Accession no. Coverage No. of contigs Genome size [bp] N50 [bp]* Illumina or
MinION data
VRES0316 E. coli ERR885454 91 104 5 123 602 197 358 Illumina
VRES0375 K. pneumoniae ERR885458 72 114 6 264 863 220 223 Illumina
VRES0377 Enterobacter cloacae complex ERR1100748 72 64 5 499 401 293 804 Illumina
VRES0379 K. oxytoca ERR1100749 52 112 6 676 582 186 596 Illumina
VRES0380 K. pneumoniae ERR885459 88 57 5 657 356 430 982 Illumina
VRES0269 R. ornithinolytica ERR885453 73 99 6 178 860 235 729 Illumina
ERR1341571
ERR1341570
35 14 6 270 467 3 218 273 MinION
NA NA 9 6 345 266 5 614 685 Both
VRES0273 Enterobacter kobei ERR885455 75 90 5 454 767 153 115 Illumina
ERR1341575
ERR1341574
42 15 5 542 520 2 782 732 MinION
NA NA 13 5 576 147 5 303 011 Both
VRES0259 R. ornithinolytica ERR1539195 654 79 6 179 725 293 454 Illumina
ERR1341573
ERR1341572
65 NA† NA† NA† MinION
NA NA 19 6 399 880 1 238 878 Both
VRES0183 K. pneumoniae ERR885457 80 68 5 544 688 300 916 Illumina
NA, Not applicable.
*N50 is a weighted median statistic. Half (50%) of the assembly is contained in contigs greater than or equal to a contig of this size.
†There is no MinION only assembly for VRES0259 as the data for this isolate was only sufficient to make a hybrid assembly.
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DISCUSSION
To our knowledge, this is the first report of CPE being
recovered from wastewater at UK sewage treatment plants.
Our demonstration of the co-circulation of a diversity of
pathogenic, carbapenem-resistant Gram-negative species
carrying different resistance genes in sewage confirms that
this is a complex and diverse reservoir. We also confirmed
that treatment processes do not prevent the release of
CPE into the environment, which will contribute to con-
tamination of river and lakes, farmland, vegetable land and
fisheries, with the potential for spread to humans and live-
stock. Human infection caused by bacteria such as those
identified here would prove challenging to treat with avail-
able antimicrobial drugs.
All CPE isolates were recovered from plants located down-
stream of hospitals. The same bacterial species and carbape-
nemase gene (encoding NDM) was found in two hospitals
and the downstream wastewater treatment plant, indicating
that the resistance mechanisms found in wastewater are
likely to mirror those associated with human disease. Cur-
rently, no national regulation nor the European Directive
91/271/EEC on urban wastewater treatment stipulates the
use of disinfection of hospital wastewater in the UK, and as
a result this may be contributing to the dissemination of
CPE [57, 58]. Further studies are required to fully ascertain
the role of hospital effluent as a source of environmental
contamination with CPE.
Phenotypic methods presumptively identify the presence of
the most common CPEs (KPC, MBL, OXA-48), but are
unable to identify variant types. We used genome sequencing
to identify variants of carbapenemase-resistance genes, to
detect sequence alterations in porin genes associated with
decreased membrane permeability (an important factor con-
tributing to carbapenem resistance [59]), and to define the full
repertoire of resistance genes. The use of long-read sequencing
data enabled us to conclude that two Enterobacteriaceae spe-
cies (R. ornithinolytica and Enterobacter kobei) in treated and
untreated wastewater carried highly similar plasmids contain-
ing numerous genes encoding resistance to antimicrobials and
(a)
E. kobei
VRES0273
R. ornithinolytica
VRES0269
(b)
R. ornithinolytica
VRES0259
10 kb
10 kb
Arsenic
resistance
Mercury
resistance
Tellurium
resistance
MDR region (sul1, sul2, qnrA1,
emrE, arr, aac6’-IIC, aac6’-Ib)
blaSHV-12 blaTEM-1
Tn1999 with blaOXA-48 
E. kobei
VRES0273
R. ornithinolytica
VRES0269
R. ornithinolytica
VRES0259
Fig. 4. Comparison of shared Enterobacter kobei and R. ornithinolytica plasmids. (a) blaOXA-48 pOXA-48a-like plasmid. (b) Multidrug-
resistance plasmid. Plasmid maps of the shared plasmids are shown, with genes of interest annotated. The grey and blue blocks rep-
resent BLAST hits between the isolates in the same orientation and inverted orientation, respectively. The colour intensity is proportional
to the per cent identity of the match, within the specific region. Gene colour code indicates function: dark blue, heavy-metal resistance;
light blue, conjugational transfer; dark pink, antibiotic resistance; light pink, IS elements and transposases; yellow, replication, mainte-
nance, partitioning genes; light green, other (hypothetical proteins, host metabolism, regulators and pseudogenes).
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heavy metals. Whilst the rate of mutation in plasmids may
vary from that of the chromosome, our findings are consistent
with the suggestion that a globally distributed blaOXA-48 plas-
mid was shared very recently between the two species (0 SNPs
different), a figure that is contextualized by comparison with a
published sequence of plasmid pOXA-48a [50], which was
more than 100 SNPs different. This plasmid is known to be
the origin of the widespread dissemination of blaOXA-48 and,
similar to our findings, has a broad bacterial host range and
does not encode additional antimicrobial-resistance genes [50,
60]. In addition, a recent report from Findlay et al. in 2017 [3]
identified OXA-48-like enzymes as being the second most fre-
quently detected carbapenemases in theWest Midlands region
of the UK between 2007 and 2014 based on a study of 119
clinical isolates, including one environmental isolate from an
endoscope camera head in a urology theatre. OXA-48-like
enzymes were identified in 16/119 isolates from three different
bacterial species (K. pneumoniae, E. coli and Citrobacterfreun-
dii). Similar to the plasmids detected in our study, five IncL/M
plasmids were identified using WGS, which exhibited
>99% identity to pOXA-48a with no additional resistance
genes. These genome data were not publicly available and no
genome comparison was possible with our data, but based on
similarity to pOXA-48a and genetic content we postulate that
a highly related plasmid encoding blaOXA-48 is found in both
UK wastewater and associated with human infection. Similar
to pOXA-48a, the blaOXA-48 gene and the transposases identi-
fied in our study are part of the Tn1999 transposon, indicating
the mobility of this gene independent of the plasmid backbone
(Fig. 4a). It has also been shown in an early characterization of
this plasmid that it is highly identical and syntenic to the
pCTX-M3 plasmid, except for the Tn1999 transposon from
which it might have evolved [50].
The multidrug and heavy-metal resistance plasmid was
highly similar in both species, although this acquisition may
have occurred less recently based on a three SNP difference
between the R. ornithinolytica and the Enterobacter kobei
plasmid. Based on the published mutation rate for K. pneu-
moniae (2.710 6 SNPs per site per year, equating to 14
SNPs per genome per year) [61], this would suggest that the
plasmids last shared a common ancestor more than 3 years
ago. Identification of such resistance plasmids spreading
within and between bacterial species is essential when trying
to understand the epidemiology of CPE, as has been shown
in studies using PacBio sequencing [9, 10]. A study by Shep-
pard et al. [10] particularly emphasizes that a similar
detailed picture of plasmid transfer and variability is not
available when only studying short-read data, which may
prove misleading.
The main limitation of this study is the lack of quantifica-
tion of CPE load per sample. This was due to technical limi-
tations relating to the incomplete selectivity of currently
available CPE media (which results in overgrowth of organ-
isms other than CPE), combined with the low prevalence of
CPE in samples. This leads to a low positive predictive value
for detection of a true CPE from the growth obtained on the
plate and makes quantitation extremely challenging. In
order to enrich for low numbers of CPE in a very high bac-
terial background, we used an additional selective enrich-
ment step (tryptic soy broth with imipenem), which
increased the yield of CPE, but ruled out quantitation. Fur-
thermore, the study was conducted in a region with very
low CPE prevalence and may not be generalizable across the
UK [62]. Future studies including longitudinal data from
additional regions and hospitals will provide further insights
into the community spread of CPE.
In conclusion, the combined use of Illumina and MinION
technologies revealed sharing of plasmids carrying multiple
antimicrobial-resistance genes between different bacterial
species in wastewater, including the plasmid encoding
OXA-48 that confers carbapenem resistance. Whilst pheno-
typic testing resolved the general class of carbapenemase
and short-read data identified the specific carbapenemase
genes involved, long-read data was essential to resolve the
plasmid architecture and for accurate comparisons. Small,
portable sequencing instruments, such as the MinION, have
the potential for use in real-time genomic surveillance in a
One Health approach that includes genetic material from
wastewater, animals and hospitals to monitor the effective-
ness of treatment systems, and to contribute to the develop-
ment of interventions to limit the dissemination of
antimicrobial resistance.
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